Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2024
Same author

Implementation of entrustable professional activities in multiple surgical residencies: A quality improvement approach.

American journal of surgery·2023
Same author

Salvage prostate bed plus elective pelvic node radiation without androgen deprivation therapy.

Journal of cancer research and clinical oncology·2023
Same author

Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation.

European urology oncology·2023
Same author

Addressing Peer-to-Peer Resident Mistreatment Through the Use of Forum Theatre: A Pilot Intervention.

Academic medicine : journal of the Association of American Medical Colleges·2022
Same author

The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis.

Clinical and translational radiation oncology·2022
Same journal

Dehydroleucodine Induces ROS-Mediated Mitochondrial Apoptosis and G2/M Cell Cycle Arrest in Oral Squamous Cell Carcinoma.

Journal of Cancer·2026
Same journal

CellVizio<sup>®</sup> System for Mesothorax Lymphadenopathy Rapid on Site, 18G needle: Pros and Cons.

Journal of Cancer·2026
Same journal

Epidemiological Trends and Shared Molecular Signatures of Pancreatic Ductal Adenocarcinoma and Diabetes: An Integrative Analysis Based on Global Burden of Disease and Gene Expression Omnibus Datasets.

Journal of Cancer·2026
Same journal

Association between obesity, sex, medical comorbidities, and survival in cancer patients treated with immune checkpoint inhibitors.

Journal of Cancer·2026
Same journal

Exosomes in Cancer Biology: Emerging Biomarkers and Therapeutic Targets.

Journal of Cancer·2026
Same journal

<i>GALNT14</i>-rs9679162 Genotypes Predict Post-immunotherapy Side Effect and Survival in Patients with Hepatitis B Virus-related Hepatocellular Carcinoma.

Journal of Cancer·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Prognostic factors for failure after prostatectomy.

Gregory P Swanson1, Joseph W Basler

  • 11. Departments of Radiation Oncology, Radiology and Urology, UT Health Science Center San Antonio, San Antonio, TX 78229, USA.

Journal of Cancer
|January 4, 2011
PubMed
Summary
This summary is machine-generated.

Immediate postoperative treatment after prostatectomy offers survival benefits for prostate cancer patients. Identifying high-risk individuals ensures appropriate adjuvant therapy is offered, balancing benefits against treatment toxicity.

Keywords:
Prostate canceradjuvant radiationadjuvant therapyhigh riskprostatectomy

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: Jun 5, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Area of Science:

  • Oncology
  • Urology
  • Surgical Oncology

Background:

  • Randomized studies demonstrate benefits of immediate postoperative treatment following prostatectomy for prostate cancer.
  • A survival advantage has been observed in some studies, yet uniform adoption of adjuvant therapy is limited.
  • Concerns exist regarding treatment toxicity versus perceived risk in certain patient subgroups.

Purpose of the Study:

  • To review predictive factors for identifying high-risk prostate cancer patients.
  • To guide the decision-making process for offering immediate adjuvant treatment post-prostatectomy.
  • To optimize treatment strategies by balancing efficacy and toxicity.

Main Methods:

  • Review of existing randomized clinical trials and relevant literature.
  • Analysis of factors influencing risk stratification in prostate cancer patients.
  • Identification of patient cohorts who would most benefit from immediate adjuvant therapy.

Main Results:

  • Evidence supports a survival benefit from immediate postoperative treatment in select prostate cancer cases.
  • Specific clinical and pathological factors can predict higher risk of recurrence or progression.
  • These factors can help justify the risks associated with adjuvant treatment.

Conclusions:

  • Immediate adjuvant treatment post-prostatectomy can improve survival in high-risk prostate cancer patients.
  • Accurate risk stratification is crucial for selecting appropriate candidates for adjuvant therapy.
  • Personalized treatment approaches are necessary to maximize benefits while minimizing toxicity.